-
Product Insights
Likelihood of Approval Analysis for Dermatological Disorders
Overview How likely is it that the drugs in Dermatological Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dermatological Disorders Overview Dermatological disorders are diseases or conditions that affect the...
-
Product Insights
Likelihood of Approval Analysis for Eosinophilic Esophagitis
Overview How likely is it that the drugs in Eosinophilic Esophagitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eosinophilic Esophagitis Overview Eosinophilic esophagitis is disease characterized by the presence of...
-
Product Insights
Likelihood of Approval Analysis for Neuroendocrine Cancer
Overview How likely is it that the drugs in Neuroendocrine Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuroendocrine Cancer Overview A neuroendocrine cancer, often referred as a neuroendocrine tumor...
-
Product Insights
Likelihood of Approval Analysis for Macular Edema
Overview How likely is it that the drugs in Macular Edema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Edema Overview Macular edema is swelling or fluid retention in a...
-
Product Insights
Likelihood of Approval Analysis for Nociceptive Pain
Overview How likely is it that the drugs in Nociceptive Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nociceptive Pain Overview Nociceptive pain is a type of pain caused by...
-
Sector Analysis
NewGeneral Hospital Supplies Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
General Hospital Supplies Market Report Overview The general hospital supplies market size was $12.7 billion in 2023. Factors such as the solid awareness about ensuring medical facilities will drive the market growth at a CAGR of more than 2% from 2023 to 2033. General hospital supplies support patient care and safety irrespective of the reason they might be visiting the hospital. General hospital supplies form the equipment base of all healthcare facilities in any country. For any kind of treatment...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Odevixibat in Biliary Atresia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Odevixibat in Biliary Atresia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Odevixibat in Biliary Atresia Drug Details: Odevixibat Sesquihydrate (Bylvay) is acts by...
-
Sector Analysis
NewNigeria Upstream (Oil and Gas) Fiscal and Regulatory Guide, 2024
The upstream fiscal and regulatory outlook of Nigeria underwent a comprehensive reform with the Petroleum Industry Act (PIA) of 2021. Nigeria has implemented different contractual regimes for oil exploration and production, including Production Sharing Agreements (PSAs), Joint Ventures and concessions in the form of Sole Risk agreements, with special conditions for marginal fields. In the latest reform, the Nigerian National Petroleum Corporation (NNPC) is replaced with a limited liability company, NNPC Ltd, and is now enabled for joint venture arrangements,...
-
Company Insights
NewAir France – Digital Transformation Strategies
Air France-KLM Digital Transformation Strategies Overview Air France has been focusing on using artificial intelligence, the Internet of Things (IoT), cloud-based mobile applications, big data, and drones to digitally transform its operations. The annual ICT spending of Air France was estimated at $911.8 million for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Air France-KLM is an international airline group specializing in air passenger transport, cargo transport, and aircraft maintenance....